Abstract
The objectives of this evaluation were to analyze the efficacy of cholesterol lowering therapy as outlined by the National Cholesterol Education Program (NCEP) guidelines and to determine the cost effectiveness of treating hyperlipidemia in the incarcerated patient. A retrospective chart review was conducted of 100 randomly selected charts identified through the pharmacy claims data. Criteria for inclusion were that patients had received at least 60 days of therapy and had a baseline LDL-C prior to drug initiation. Seventy-nine patients met these criteria. Overall, 71% (56) of patients achieved NCEP 2 goal LDL-C. Forty-five percent of patients with coronary heart disease (CHD) achieved a goal LDL-C of less than 100 mg/dL. Ninety-five percent of patients were compliant with their therapy (at least five refills in six months). It was hypothesized that over five years the system will prevent one CHD patient from having a coronary procedure and two fatal coronary events in the population reviewed. The results of this review reinforce the importance of effectively managing hyperlipidemia in a state correctional system.
Get full access to this article
View all access options for this article.